Glaukos Corp (GKOS)
144.00
+3.17
(+2.25%)
USD |
NYSE |
Nov 22, 16:00
144.11
+0.11
(+0.08%)
After-Hours: 20:00
Glaukos Cash from Financing (Quarterly): 9.668M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 9.668M |
| June 30, 2024 | 8.592M |
| March 31, 2024 | 13.17M |
| December 31, 2023 | 7.303M |
| September 30, 2023 | 7.467M |
| June 30, 2023 | -0.88M |
| March 31, 2023 | 1.152M |
| December 31, 2022 | 0.529M |
| September 30, 2022 | 4.206M |
| June 30, 2022 | 0.106M |
| March 31, 2022 | 1.41M |
| December 31, 2021 | 1.617M |
| September 30, 2021 | 3.867M |
| June 30, 2021 | 16.36M |
| March 31, 2021 | 17.41M |
| December 31, 2020 | 8.659M |
| September 30, 2020 | 5.821M |
| June 30, 2020 | 243.84M |
| March 31, 2020 | 4.22M |
| December 31, 2019 | -22.04M |
| September 30, 2019 | 6.666M |
| June 30, 2019 | 0.318M |
| Date | Value |
|---|---|
| March 31, 2019 | 5.407M |
| December 31, 2018 | 1.974M |
| September 30, 2018 | 13.93M |
| June 30, 2018 | 2.836M |
| March 31, 2018 | 2.84M |
| December 31, 2017 | 0.433M |
| September 30, 2017 | 0.484M |
| June 30, 2017 | 1.78M |
| March 31, 2017 | 1.97M |
| December 31, 2016 | 0.422M |
| September 30, 2016 | -0.911M |
| June 30, 2016 | 0.55M |
| March 31, 2016 | -1.703M |
| December 31, 2015 | -0.988M |
| September 30, 2015 | -10.08M |
| June 30, 2015 | 115.01M |
| March 31, 2015 | 3.166M |
| December 31, 2014 | 1.933M |
| September 30, 2014 | 0.076M |
| June 30, 2014 | 0.273M |
| March 31, 2014 | 1.218M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-22.04M
Minimum
Dec 2019
243.84M
Maximum
Jun 2020
16.62M
Average
5.020M
Median
Cash from Financing (Quarterly) Benchmarks
| Boston Scientific Corp | 7.00M |
| Baxter International Inc | -146.00M |
| Masimo Corp | -1.60M |
| Teleflex Inc | -174.82M |
| Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.586M |
| Cash from Investing (Quarterly) | 30.56M |
| Free Cash Flow | -81.27M |
| Free Cash Flow Per Share (Quarterly) | -0.2005 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -11.04M |
| Free Cash Flow Yield | -1.11% |